分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

LncRNA THOR increases osteosarcoma cell stemness and migration by enhancing SOX9 mRNA stability

Haojun Wu, Yanxia He, Hang Chen, Yanzhi Liu, Bo Wei, Guanghua Chen, Han Lin, Hao Lin

Journal:FEBS Open Bio

IF:1.96

DOI:10.1002/2211-5463.12620

PMID:30984551

Published:2019-03-02

research field:神经科学自噬转录调控脂质代谢免疫代谢脑血管病神经炎症

Abstract

Although the long non-coding RNA THOR has been reported to promote cancer stem cell expansion in liver cancer and gastric cancer, its effects on osteosarcoma (OS) cells remain unclear. Here, we investigated the roles of THOR in the stemness and migration of OS cells. We report that the level of THOR is remarkably upregulated in OS cell spheroids compared to that in OS adherent cells. THOR overexpression increased spheroid formation ability and aldehyde dehydrogenase 1 (ALDH1) activity in OS adherent cells, and the opposite effect was observed in spheroids with THOR knockdown. Additionally, the spheroids formed by OS adherent cells exhibited a stronger migration ability, which was attenuated by THOR knockdown, and THOR overexpression increased OS cell migration. Mechanistically, mRNA stability, luciferase reporter, and RNA–RNA in vitro interaction assays indicated that THOR can directly bind to the middle region of the SOX9 3′-untranslated region (UTR), and enhances its mRNA stability, thereby increasing its expression. Notably, SOX9 knockdown reduced the ability of THOR overexpression to promote the stemness of OS cells. These findings indicate that the lncRNA THOR can promote the stemness and migration of OS cells by directly binding to the middle region of SOX9 3′UTR, thereby enhancing SOX9 mRNA stability and increasing its expression; thus, we provide information that may be of use in identifying potential targets for OS treatment.

本文使用的Yeasen产品

购物车
客服
转染试用